Bascom Ventures — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
HealthMyne develops QIDS, a quantitative imaging and clinical decision support platform for oncology care teams that tracks incidental findings, supports tumor conference preparation, and provides quantitative imaging metrics such as lesion volume and texture analysis.
AI & Machine LearningDigital HealthHealthtechMedical DevicesMadison, US
Roger Chylla(Executive Officer, Director)inHao Wang(Executive Officer)inPraveen Sinha(Executive Officer, Director)inArvind Subramanian(Executive Officer, Director)inThomas Rockwell Mackie(Director)
BoardGreg Robinson(Director)
Co-investorsAlumni VenturesAscension Ventures4490 Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




